Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Low-Dose Ibuprofen for Cognitive Problems in Patients With Cancer

NCT03186638 is registered in ClinicalTrials.gov with University of Rochester NCORP Research Base as lead sponsor.

NCT NCT03186638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03186638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Low-Dose Ibuprofen for Cognitive Problems in Patients With Cancer
Lead sponsor
University of Rochester NCORP Research Base
Phase
Phase 2
Overall status
Completed
Start date
May 26, 2017
Completion date
June 1, 2022
Enrollment
87 (actual)
Sites
169

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, malignant neoplasm